International

Oslo, Norway - DoMore Diagnostics, a leader in cancer outcome prediction with pathology AI algorithms, today announced that it has achieved CE-IVD mark for the Histotype Px  Colorectal, a deep learning algorithm that predict patient outcome...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups. This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5...

Leica Biosystems: Powered by Universal Access, the BOND-PRIME Advanced Staining Solution Enables Labs to Seamlessly Adapt to Any Incoming Workflows MELBOURNE, AUS. – Leica Biosystems is launching BOND-PRIME, a premium...

Today marks the beginning of a new era in the field of cancer diagnosis and precision medicine with the coming together of two leading organizations Crosscope Inc. a Silicon Valley-based leader and provider of Vendor Agnostic AI-enabled Digital...

DUBLIN, Ireland, May 19th 2022— Deciphex, a leading provider of pathology software and services, announced today the closing of a $11.5 million Series B funding round. The round was led by ACT Venture Capital, with Charles River...

LAUSANNE, Switzerland and ALBUQUERQUE, N.M. – May 12, 2022 – 5 pm (CET) | 9 am MDT – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of...